Ingredients Categories

Ready-to-Market Omega-3 Bonded to Phospholipids backed by Clinical Results | Ruby-O® Balance

11 May 2026

Video

Ready-to-Market Omega-3 Bonded to Phospholipids backed by Clinical Results | Ruby-O® Balance

A newly published clinical study evaluated Ruby-O® BPL-O3™, Naturmega’s bonded phospholipid omega-3 platform.

Despite a lower daily dose (825 mg EPA + DHA), Ruby-O® Balance achieved up to 3x greater triglyceride target attainment compared to standard triglyceride fish oil, along with significant improvements in Omega-3 Index.